Works matching IS 00126667 AND DT 2022 AND VI 82 AND IP 1

Results: 13

Maralixibat: First Approval.

Published in:

Drugs, 2022, v. 82, n. 1, p. 71, doi. 10.1007/s40265-021-01649-0

By:

Shirley, Matt

Publication type:

Article

Atogepant: First Approval.

Published in:

Drugs, 2022, v. 82, n. 1, p. 65, doi. 10.1007/s40265-021-01644-5

By:

Deeks, Emma D.

Publication type:

Article

Correction to: Maralixibat: First Approval.

Published in:

2022

By:

Shirley, Matt

Publication type:

Correction Notice

Correction to: Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis.

Published in:

2022

By:

Kang, Connie;
Blair, Hannah A.

Publication type:

Correction Notice

Optimized Dosing: The Next Step in Precision Medicine in Non-Small-Cell Lung Cancer.

Published in:

Drugs, 2022, v. 82, n. 1, p. 15, doi. 10.1007/s40265-021-01654-3

By:

Boosman, René J.;
Burgers, Jacobus A.;
Smit, Egbert F.;
Steeghs, Neeltje;
van der Wekken, Anthonie J.;
Beijnen, Jos H.;
Huitema, Alwin D. R.;
ter Heine, Rob

Publication type:

Article

Drug Treatment of Cluster Headache.

Published in:

Drugs, 2022, v. 82, n. 1, p. 33, doi. 10.1007/s40265-021-01658-z

By:

Diener, Hans Christoph;
May, Arne

Publication type:

Article

Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis.

Published in:

Drugs, 2022, v. 82, n. 1, p. 55, doi. 10.1007/s40265-021-01650-7

By:

Kang, Connie;
Blair, Hannah A.

Publication type:

Article

Correction to: Efmoroctocog Alfa: A Review in Haemophilia A.

Published in:

2022

By:

Frampton, James E.

Publication type:

Correction Notice

Correction to: Infigratinib: First Approval.

Published in:

2022

By:

Kang, Connie

Publication type:

Correction Notice

Chiglitazar: First Approval.

Published in:

Drugs, 2022, v. 82, n. 1, p. 87, doi. 10.1007/s40265-021-01648-1

By:

Deeks, Emma D.

Publication type:

Article

Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Use Associated with Reduced Mortality and Other Disease Outcomes in US Veterans with COVID-19.

Published in:

Drugs, 2022, v. 82, n. 1, p. 43, doi. 10.1007/s40265-021-01639-2

By:

Rizk, John G.;
Wenziger, Cachet;
Tran, Diana;
Hashemi, Leila;
Moradi, Hamid;
Streja, Elani;
Ahluwalia, Amrita

Publication type:

Article

Rationale and Clinical Use of Bronchodilators in Adults with Bronchiectasis.

Published in:

Drugs, 2022, v. 82, n. 1, p. 1, doi. 10.1007/s40265-021-01646-3

By:

Martínez-García, Miguel Ángel;
Oscullo, Grace;
García-Ortega, Alberto;
Matera, Maria Gabriella;
Rogliani, Paola;
Cazzola, Mario

Publication type:

Article

Avacopan: First Approval.

Published in:

Drugs, 2022, v. 82, n. 1, p. 79, doi. 10.1007/s40265-021-01643-6

By:

Lee, Arnold

Publication type:

Article